Summary of Key Points Core Viewpoint - The company, Shaanxi Meibang Pharmaceutical Group Co., Ltd., has provided a guarantee of RMB 67 million for its wholly-owned subsidiary, Shaanxi Nozheng Biotechnology Co., Ltd., to support a bank loan for the construction of a pesticide production line [1][2]. Group 1: Guarantee Details - The guarantee amount provided by the company is RMB 67 million, which is the total actual guarantee balance as of the announcement date [1]. - The loan is secured through a contract with Agricultural Bank of China for a term of 7 years, aimed at funding the first phase of a project to produce 20,000 tons of pesticide raw materials and intermediates [1][2]. - There are no counter-guarantees associated with this guarantee, and there are no overdue guarantees reported [1]. Group 2: Internal Decision-Making Process - The company held meetings on April 24, 2025, to approve the guarantee for its subsidiaries, allowing a total guarantee limit of up to RMB 700 million for the year 2025 [2]. - Prior to this guarantee, the company had no outstanding guarantees for Nozheng Biotechnology, with a remaining guarantee capacity of RMB 250 million [2]. Group 3: Subsidiary Information - Shaanxi Nozheng Biotechnology Co., Ltd. was established on March 26, 2007, with a registered capital of RMB 100 million, and operates in the pesticide and chemical intermediate sectors [3][4]. - The company has a good credit status with no significant issues affecting its debt repayment ability [4]. Group 4: Necessity and Reasonableness of the Guarantee - The guarantee is deemed necessary for supporting the subsidiary's bank loan application, allowing the company to effectively control operational risks and maintain oversight of its credit status [4]. Group 5: Board Opinions - The board of directors supports the provision of guarantees to subsidiaries to enhance operational efficiency and align with the interests of the company and its shareholders [4]. Group 6: Overall Guarantee Status - As of the announcement date, the total guarantees provided by the company to its subsidiaries amount to RMB 700 million, representing 62.24% of the company's audited net assets for 2024 [4].